Indian Shares Rise as Investors Focus on Earnings
Indian stocks rebounded with the Sensex gaining 482 points, driven by gains in metal and pharma sectors, as investors assessed earnings reports.
Indian stocks rebounded with the Sensex gaining 482 points, driven by gains in metal and pharma sectors, as investors assessed earnings reports.
Glaxosmithkline Pharmaceuticals is currently trading at Rs. 2807.00, up by 7.80 points or 0.28% from its previous closing of Rs. 2799.20 on…
Glenmark Pharmaceuticals’ arm — Glenmark Life Sciences is on track to more than double its capacity over the next four years at…
The US Food and Drug Administration (USFDA) has completed an inspection at Alembic Pharmaceuticals’ general oral solid formulation facility at Panelav, Gujarat,…
Laurus Labs has transferred the US Food and Drug Administration (USFDA) approved Abbreviated New Drug Application (ANDA) of Tenofovir Disoproxil Fumarate (TDF)…
Alembic Pharmaceuticals has reported results for second quarter ended September 30, 2018. The company has reported over 2 fold jump in its…
GlaxoSmithKline Pharmaceuticals has reported results for second quarter ended September 30, 2018. The company has reported a fall of 22.67% in its…